Art. 1 Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December…

Purpose

In forcesince 7 Aug 2009cited 3×

The purpose of this Regulation is to lay down a Community procedure for the designation of medicinal products as orphan medicinal products and to provide incentives for the research, development and placing on the market of designated orphan medicinal products.

  • Judgment of the General Court (Tenth Chamber) of 23 September 2020 (Extracts). Medac Gesellschaft für klinische Spezialpräparate mbH v EuropDecision

    Regard being had to the fact that some conditions occur so infrequently that the pharmaceutical industry would be unwilling to develop medicinal products to diagnose, prevent or treat them under normal market conditions (recital 1 of …

    23 Sep 2020 · 62019TJ0549

  • Judgment of the Court (Eighth Chamber) of 4 October 2024. Mylan IRE Healthcare Ltd v European Commission.Decision

    Съгласно член 1 от Регламент (ЕО) № 141/2000 на Европейския парламент и на Съвета от 16 декември 1999 година за лекарствата сираци (ОВ L 18, …

    4 Oct 2024 · 62022CJ0237

  • Conclusions de l'avocat général M. J. Richard de la Tour, présentées le 5 novembre 2026.Decision

    … řízení na obsazení místa procuratore dello Stato( 20 ) z důvodu, že překročil věkovou hranici stanovenou článkem 1 nařízení předsedy Rady ministrů č. 141/2000 ve znění nařízení prezidenta republiky č. 161/2011 na 35 …

    5 Nov 2026 · 62025CC0606